1. Home
  2. GERN
  3. GERN News

Latest Geron Corporation (GERN) News on November 17, 2024

Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
GERN

Business Wire

6 days ago

Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development

Geron to Participate in the Stifel 2024 Healthcare Conference
GERN

Business Wire

6 days ago

Geron to Participate in the Stifel 2024 Healthcare Conference

Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results
GERN

Simply Wall St.

7 days ago

Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results

Geron Third Quarter 2024 Earnings: Beats Expectations
GERN

Simply Wall St.

8 days ago

Geron Third Quarter 2024 Earnings: Beats Expectations

Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytelo Launch and Strategic ...
GERN

GuruFocus.com

9 days ago

Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytelo Launch and Strategic ...

Geron Secures $250M Funding and Strong Q3 Sales
GERN

TipRanks

9 days ago

Geron Secures $250M Funding and Strong Q3 Sales

Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value
GERN

BioPharma Dive

9 days ago

Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value

Geron (GERN) Q3 2024 Earnings Call Transcript
GERN

Motley Fool

10 days ago

Geron (GERN) Q3 2024 Earnings Call Transcript

GERN

MT Newswires

10 days ago

Geron Secures up to $375 Million in Funding with Royalty Pharma, Pharmakon Advisors

GERN

MT Newswires

10 days ago

Geron's Q3 Loss Narrows, Revenue Increases

Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates
GERN

Zacks

10 days ago

Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates

GERN

Associated Press Finance

10 days ago

Geron: Q3 Earnings Snapshot

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
GERN

GlobeNewswire

10 days ago

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million

Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
GERN

Business Wire

10 days ago

Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors

Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights
GERN

Business Wire

10 days ago

Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies
GERN

Business Wire

12 days ago

Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

a month ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds?
GERN

Insider Monkey

a month ago

Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds?

GERN

MT Newswires

a month ago

Scotiabank Initiates Geron at Sector Outperform With $6 Price Target

Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024
GERN

Business Wire

a month ago

Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024

Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy?
GERN

Insider Monkey

a month ago

Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy?

Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential?
GERN

Insider Monkey

a month ago

Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential?

Geron Corp (GERN) Q2 2024 Earnings Call Highlights: Strong Financial Position Amid Early Rytelo ...
GERN

GuruFocus.com

a month ago

Geron Corp (GERN) Q2 2024 Earnings Call Highlights: Strong Financial Position Amid Early Rytelo ...

Wall Street Analysts Rate Geron Corporation (GERN) as a Buy Amid Strong Growth Prospects
GERN

Insider Monkey

a month ago

Wall Street Analysts Rate Geron Corporation (GERN) as a Buy Amid Strong Growth Prospects

Geron Corporation (GERN): A Hot Stock to Buy Now
GERN

Insider Monkey

a month ago

Geron Corporation (GERN): A Hot Stock to Buy Now

Is Geron Corporation (GERN) the Best NASDAQ Stock Under $5?
GERN

Insider Monkey

a month ago

Is Geron Corporation (GERN) the Best NASDAQ Stock Under $5?

High Growth Tech Stocks To Watch This October 2024
GERN

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch This October 2024

When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)?
GERN

Simply Wall St.

2 months ago

When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)?

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

2 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corp. (GERN): Short Seller Sentiment is Bearish on This Cancer Stock
GERN

Insider Monkey

2 months ago

Geron Corp. (GERN): Short Seller Sentiment is Bearish on This Cancer Stock

Geron Corp. (GERN): Fast-Growing Penny Stock To Consider
GERN

Insider Monkey

2 months ago

Geron Corp. (GERN): Fast-Growing Penny Stock To Consider

Geron Corporation (NASDAQ:GERN): Hedge Funds Are Bullish On This US Stock to Buy Under $5 Now
GERN

Insider Monkey

2 months ago

Geron Corporation (NASDAQ:GERN): Hedge Funds Are Bullish On This US Stock to Buy Under $5 Now

GERN

MT Newswires

2 months ago

Geron Appoints Jim Ziegler as Chief Commercial Officer

Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer
GERN

Business Wire

2 months ago

Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer

GERN

MT Newswires

2 months ago

Leerink Partners Initiates Coverage on Geron With Outperform Rating, $7 Price Target

High Growth Tech Stocks To Watch In September 2024
GERN

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In September 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

3 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Investing in Geron (NASDAQ:GERN) three years ago would have delivered you a 285% gain
GERN

Simply Wall St.

3 months ago

Investing in Geron (NASDAQ:GERN) three years ago would have delivered you a 285% gain

Geron Second Quarter 2024 Earnings: Beats Expectations
GERN

Simply Wall St.

3 months ago

Geron Second Quarter 2024 Earnings: Beats Expectations

GERN

MT Newswires

3 months ago

B. Riley Adjusts Price Target on Geron to $5.50 From $5, Maintains Buy Rating

Geron (GERN) Q2 2024 Earnings Call Transcript
GERN

Motley Fool

3 months ago

Geron (GERN) Q2 2024 Earnings Call Transcript

GERN

MT Newswires

3 months ago

Geron Q2 Net Loss Widens, Revenue Rises

Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
GERN

Zacks

3 months ago

Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates

GERN

Associated Press Finance

3 months ago

Geron: Q2 Earnings Snapshot

Geron Corporation Reports Second Quarter 2024 Financial Results and Business Highlights
GERN

Business Wire

3 months ago

Geron Corporation Reports Second Quarter 2024 Financial Results and Business Highlights

GERN

MT Newswires

4 months ago

Geron's Rytelo Gets NCCN Recommendation for Treatment of Symptomatic Anemia in Myelodysplastic Syndromes

Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS
GERN

Business Wire

4 months ago

Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS

Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
GERN

BioPharma Dive

4 months ago

Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board

GERN

MT Newswires

4 months ago

Update: Geron Chief Commercial Officer Anil Kapur to Leave at End of August; Shares Drop Premarket

GERN

MT Newswires

4 months ago

Geron Chief Commercial Officer Anil Kapur to Leave at the End of August

Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024
GERN

Business Wire

4 months ago

Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024

Geron (GERN) to Report Q2 Earnings: What's in the Cards?
GERN

Zacks

4 months ago

Geron (GERN) to Report Q2 Earnings: What's in the Cards?

Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024
GERN

Business Wire

4 months ago

Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

5 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation's (NASDAQ:GERN) large institutional owners must be happy as stock continues to impress, up 27% over the past week
GERN

Simply Wall St.

5 months ago

Geron Corporation's (NASDAQ:GERN) large institutional owners must be happy as stock continues to impress, up 27% over the past week

GERN

MT Newswires

5 months ago

Geron Insider Sold Shares Worth $1,334,129, According to a Recent SEC Filing

Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
GERN

Zacks

5 months ago

Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up

GERN

MT Newswires

5 months ago

Barclays Initiates Geron at Overweight Rating With $9 Price Target

GERN

MT Newswires

5 months ago

Stifel Nicolaus Adjusts Geron Price Target to $7 From $6, Maintains Buy Rating

Is Geron Stock a Buy Following Its First New Drug Approval?
GERN

Motley Fool

5 months ago

Is Geron Stock a Buy Following Its First New Drug Approval?

Geron stock pops on FDA approval for blood cancer drug
GERN

Yahoo Finance Video

5 months ago

Geron stock pops on FDA approval for blood cancer drug

GERN

MT Newswires

5 months ago

Wedbush Raises Geron's Price Target to $8 From $7, Outperform Rating Maintained

GERN

MT Newswires

5 months ago

Sector Update: Health Care Stocks Advance Friday Afternoon

GERN

MT Newswires

5 months ago

Top Midday Gainers

Stocks shrug off hot jobs report, GameStop sinks, Nvidia stock split on tap: Yahoo Finance
GERN

Yahoo Finance Video

5 months ago

Stocks shrug off hot jobs report, GameStop sinks, Nvidia stock split on tap: Yahoo Finance

Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?
GERN

Zacks

5 months ago

Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?

GERN

MT Newswires

5 months ago

Needham Adjusts Geron Price Target to $6 From $5, Maintains Buy Rating

FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
GERN

Benzinga

5 months ago

FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug

GERN

MT Newswires

5 months ago

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

GERN

MT Newswires

5 months ago

Sector Update: Health Care

GERN

MT Newswires

5 months ago

Top Premarket Gainers

GERN

MT Newswires

5 months ago

Geron Receives FDA Approval for Leukemia Treatment Rytelo; Shares Rise Pre-Bell

FDA approves Geron’s RYTELO for MDS associated anaemia
GERN

Pharmaceutical Technology

5 months ago

FDA approves Geron’s RYTELO for MDS associated anaemia

GERN

Investing.com

5 months ago

GameStop, DocuSign fall premarket; Lyft, Geron rise

Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
GERN

Business Wire

5 months ago

Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia

Why Is Ligand (LGND) Up 4% Since Last Earnings Report?
GERN

Zacks

5 months ago

Why Is Ligand (LGND) Up 4% Since Last Earnings Report?

Why Is Vertex (VRTX) Up 15.8% Since Last Earnings Report?
GERN

Zacks

5 months ago

Why Is Vertex (VRTX) Up 15.8% Since Last Earnings Report?

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

6 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript
GERN

Insider Monkey

6 months ago

Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript

GERN

MT Newswires

6 months ago

Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating

This Is Why Geron Corporation's (NASDAQ:GERN) CEO Compensation Looks Appropriate
GERN

Simply Wall St.

6 months ago

This Is Why Geron Corporation's (NASDAQ:GERN) CEO Compensation Looks Appropriate

GERN

GuruFocus.com

6 months ago

Geron Corp (GERN) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves and Financial Health

Geron (GERN) Q1 2024 Earnings Call Transcript
GERN

Motley Fool

6 months ago

Geron (GERN) Q1 2024 Earnings Call Transcript

GERN

Thomson Reuters StreetEvents

6 months ago

Q1 2024 Geron Corp Earnings Call

GERN

MT Newswires

7 months ago

Geron Shares Decline After Q1 Loss Widens

Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
GERN

Zacks

7 months ago

Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates

GERN

Associated Press Finance

7 months ago

Geron: Q1 Earnings Snapshot

Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
GERN

Business Wire

7 months ago

Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights

GERN

MT Newswires

7 months ago

Baird Downgrades Geron to Neutral From Outperform, Price Target at $4.50

GERN

MT Newswires

7 months ago

TD Cowen Initiates Geron With Buy Rating, $10 Price Target

Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
GERN

Business Wire

7 months ago

Geron to Announce First Quarter 2024 Financial Results on May 2, 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

7 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future
GERN

Simply Wall St.

7 months ago

Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future

Geron to Participate at Upcoming Investor Conferences in April
GERN

Business Wire

7 months ago

Geron to Participate at Upcoming Investor Conferences in April

5 FDA decisions to watch in the second quarter
GERN

BioPharma Dive

8 months ago

5 FDA decisions to watch in the second quarter

Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
GERN

Zacks

8 months ago

Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More

Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
GERN

Business Wire

8 months ago

Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Geron, Madrigal Pharmaceuticals jump on good news from FDA
GERN

Yahoo Finance Video

8 months ago

Geron, Madrigal Pharmaceuticals jump on good news from FDA

Stocks to Watch Friday: Adobe, Ulta, Fisker
GERN

The Wall Street Journal

8 months ago

Stocks to Watch Friday: Adobe, Ulta, Fisker

Geron (GERN) Gets ODAC Votes for Blood Disorder Drug, Shares Up
GERN

Zacks

8 months ago

Geron (GERN) Gets ODAC Votes for Blood Disorder Drug, Shares Up

Share on Social Networks: